Cyclic GMP-dependent protein kinase activation in the absence of negative inotropic effects in the rat ventricle

British Journal of Pharmacology
K L MacDonell, J Diamond

Abstract

1. It has been suggested that activation of cyclic GMP-dependent protein kinase (PKG) is a necessary step in the chain of events leading to the production of negative inotropy by muscarinic receptor agonists in mammalian ventricles, and that some cyclic GMP-elevating agents, such as sodium nitroprusside (SNP), fail to exert a negative inotropic effect because they elevate cyclic GMP levels in a pool that does not activate the kinase. This hypothesis was tested in the present study by monitoring the effects of carbachol, SNP and atrial natriuretic peptide (ANP) on contractility, cyclic GMP content and PKG activity in rat intact ventricular preparations and freshly isolated ventricular cardiomyocytes. 2. The presence of PKG in both the intact vehicle and in isolated ventricular cardiomyocytes was confirmed by MonoQ anion exchange chromatography and Western blotting. The elution profile indicated that the conditions of the PKG assay were selective for measuring PKG activity. 3. Carbachol induced a marked negative inotropic effect in intact, perfused hearts and ventricular strips in the presence of isoproterenol. The negative inotropic effect of carbachol was not associated with significant changes in cyclic GMP content or PKG acti...Continue Reading

References

Dec 7, 1977·Biochemical and Biophysical Research Communications·J DiamondA J Trapani
Feb 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·P F MéryR Fischmeister
Aug 1, 1991·The Journal of Physiology·J A SmithM J Lewis
Sep 29, 1989·Biochemical and Biophysical Research Communications·L Neyses, H Vetter
Jan 1, 1985·Annual Review of Pharmacology and Toxicology·T C Westfall, M J Meldrum
Jun 1, 1970·Proceedings of the National Academy of Sciences of the United States of America·W J GeorgeN D Goldberg
Aug 17, 1981·Biochimica Et Biophysica Acta·T M Lincoln, S L Keely
Feb 15, 1983·European Journal of Biochemistry·F Hofmann, V Flockerzi
Jan 1, 1983·Methods in Enzymology·T M Lincoln
Jan 1, 1984·British Journal of Pharmacology·I W Rodger, M Shahid
Dec 1, 1995·British Journal of Pharmacology·H NawrathH Oelert
Nov 1, 1992·Trends in Cardiovascular Medicine·J H Brown, E A Martinson

❮ Previous
Next ❯

Citations

Feb 12, 2011·Heart and Vessels·Kursat DericiEmine Demirel-Yilmaz
Feb 6, 2004·Pharmacology & Therapeutics·Savio P D'SouzaGary F Baxter
Sep 28, 1999·British Journal of Pharmacology·J M BrusqJ Kirilovsky
Jan 19, 2000·Nitric Oxide : Biology and Chemistry·A GandhiH R Weiss
Jul 14, 2007·Circulation Research·Lin YangSteven O Marx

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.